Drug Development – 3 day course
Drug development projects are often initiated by identifying treatment for a disease. The project usually contains a deep knowledge of the disease and the biological mechanism. However, in order to develop a drug for the disease, a broad knowledge of many different areas is required. This three-day course provides insights into all the parts that should be addressed to effectively target a drug project. This course is available as a traditional and as an online course. Traditional participant also have the opportunity to add lectures online. The course is organized in cooperation with SwedenBIO.
Who should attend?
The course is aimed for those involved in drug development (eg in small and medium-sized companies), and needs a comprehensive picture of the complex development chain. During the course you will get insight into how to work in the different stages of development, what to think about and what pitfalls there are on the road. To get the most exchange of the course, it is an advantage to have a natural science background. This course's main focus is on small molecules.
All lecturers have experience from drug development and most have worked with or in small drug development companies.
Starting a development project/TPP
In vitro pharmacology
Assay development and library screening
Drug metabolism and metabolic drug-drug interactions
Non clinical safety studies
Preclinical development and CMC
Preclinical formulation & analytics
Production of active pharmaceutical ingredient
Manufacturing of clinical material for biopharmaceuticals
Analysis and formulation of biologics
Pharmaceutical development incl. manufacturing and quality
Health economics and reimbursement
Medical Products Agency
Licensing Strategies among Big Pharma
Market, phase IV & post reg. phase
day 1 ca 8:30-17:30
day 2 ca 08:30-17:30
day 3 ca 08:30-16:30
Tuulikki Lindmark, Disruptive Materials
Björn Ursing, SwedenBIO
Apotekarsocieteten, Wallingatan 26A, Stockholm.
Coming events: Events in English
|18th Swedish Proteomic Society Symposium|
|The 2019 Scheele Symposium: CRISPR-Cas and gene therapy|
|Software as a Medical Device – How to meet the new regulatory challenges|
| 9 mar|
|Materials for future drug products|
|EUFEPS Annual Meeting 2020 Bridging the gap between the patient and the product design|
Drug Development - 3 day course
End date: 2019-10-17
No. of days: 3
10900 SEK Traditional participant
8300 SEK Traditional participant, SwedenBIO member
All prices are excl VAT.
i Stockholm AB
111 81 Stockholm
Besöksadress: Wallingatan 26 A
Tel: 08-723 50 00
Fax: 08-20 55 11